Loading the company…
Loading the company…
Families: Cholecystectomy & appendectomy, Bariatric surgery, Antireflux & hiatal hernia surgery, Colorectal resection.
All companies · Product and company coverage
In the last ten years FDA made 8 decisions for Lexington Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 4 procedure families, the most in 2018 (3). The latest was on 2025-07-11.
| Family | Decisions on record |
|---|---|
| Cholecystectomy & appendectomy | 8 |
| Bariatric surgery | 7 |
| Antireflux & hiatal hernia surgery | 7 |
| Colorectal resection | 7 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2025-07-11 | 510(k) | K251482 | AEON Endoscopic Powered Stapler |
| 2024-05-07 | 510(k) | K234039 | AEON Endoscopic Powered Stapler (Short/AEPH060); AEON Endoscopic Powered Stapler (Medium/AEPH160); AEON Endoscopic Powered Stapler (Long/AEPH260) |
| 2023-04-21 | 510(k) | K222210 | AEON Endoscopic Stapler |
| 2020-10-09 | 510(k) | K201882 | AEON Endoscopic Stapler |
| 2018-11-28 | 510(k) |
In 2025, Lexington Medical reported engagement with 129 surgeons and other clinicians in the states MedaRep covers, worth $94K in consulting, speaking, meals and travel for its device products, the most in Arkansas ($59K to 1). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Arkansas ($59K, 1 engaged), Connecticut ($19K, 2 engaged), California ($8,622, 1 engaged), Florida ($3,501, 40 engaged), Texas ($2,216, 32 engaged).
| K182380 |
| AEON Endoscopic Stapler |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Lexington Medical.